Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayApr 04, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF), Building a House of Brands, Is Creating World-Class Standards for Environmental Impact, Social Justice, and Corporate Governance, to Navigate Increasing Commoditization in its Market Segment

Red White & Bloom, a multi-state operator in cannabis and hemp-derived product lines, has built a platform to strengthen its brands, enabling it to wade through the difficulties of increasing product commoditization The company expects to showcase the results of the buildout process in the coming months RWB is also committed to fostering public and local input, equitable leadership opportunities, and removing systemic structures that marginalize segments of society A Boston Consulting Group (“BCG”) article entitled “Escaping the Doghouse: Winning in Commoditized Markets” notes that a company needs a clear roadmap that shows how it can reorganize itself for the…

Continue Reading

MondayApr 04, 2022 9:00 am

Hollywall Entertainment Inc. (HWAL) Dedicated to Extending Broadband, Fiber Services to Communications Tech ‘Deserts’

Hollywall Entertainment Inc. is a widely diversified technology and broadcasting company, with revenue streams derived from an extensive catalog of music, film, television, software and game library rights The company is dedicated to ensuring rural communities largely bereft of reliable communications technology embodied in broadband Internet are able to gain access to quality and affordable services The war in Ukraine has served to highlight the importance of Internet access beyond mere entertainment value, as the country’s citizens struggle to maintain “life-saving services online" Amid the disruptions to society and normal daily activity engendered by the war in Ukraine, the difficulty…

Continue Reading

FridayApr 01, 2022 9:15 am

Rebranding Efforts Aimed at Better Describing Triccar Inc.’s New Business Model, Identity Moving Forward: Correlate Infrastructure Partners Inc. (CIPI)

Triccar Inc. completed the acquisition of Correlate Inc. and Loyal Enterprises LLC (dba Solar Sight Design) in December last year, setting the wheels in motion for a rebrand In a recent news release, the company announced a majority of its shareholders had consented to a name change that will see Triccar Inc. rebrand as Correlate Infrastructure Partners as well as adopt a new symbol, subject to approvals The combined company conflates related services that position Correlate Infrastructure Partners to tap into the portfolio energy optimization market, which is valued at $290 billion Only 3% of the buildings and infrastructure in…

Continue Reading

FridayApr 01, 2022 9:00 am

Nowigence Inc.’s (NOWG) Pluaris App Provides Ideal Solution for One Billion Knowledge Workers Around the World

Globally, there are one billion knowledge workers whose jobs require them to combine action with a level of domain expertise Providing these workers with information, tools they need to succeed is key Nowigence’s Pluaris app works 24/7 to turn narrative-intensive information into scrollable intelligence Cultivating and supporting a new generation of knowledge workers is “one of the great challenges of the modern era,” according to a recent “Forbes” article (https://nnw.fm/FMUZa). Nowigence Inc. (NOWG) is up for the challenge, having created Pluaris, a powerful, proprietary platform that assists readers with automated reading and analysis of textual data. “There are currently about one…

Continue Reading

FridayApr 01, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Technology Continues to Showcase Ability to Improve Effectiveness of Existing Drug Brands

Health and wellness drug product innovator Lexaria Bioscience has developed a patented technology — DehydraTECH (TM) — which enhances the bioavailability of fat-soluble drugs and molecules Lexaria continues to research DehydraTECH’s ability to improve the speed and bioavailability of cannabidiol (“CBD”) in treating high blood pressure and epileptic conditions The company continues its research demonstrating the ability of its technology -to enhance the performance of antiviral drugs and other active pharmaceutical ingredients Sublicensing DehydraTECH continues to create revenues for the company Lexaria has additionally pursued the use of its drug-enhancing technology, in partnership with sublicensees, for making adult-use recreational cannabis…

Continue Reading

FridayApr 01, 2022 9:00 am

Eat Well Investment Group Inc.’s (CSE: EWG) (OTC: EWGFF) CEO and Director Offers Shareholder Update on The Power Play by The Market Herald

Eat Well Group released a shareholder update letter from the company’s CEO and Director, Marc Aneed, on March 8, 2022, detailing the company’s history, the progress it has made so far along with the plans that it has for the new year While appearing on an interview on The Power Play by The Market Herald, Mr. Aneed covered the contents of the shareholder letter while also reiterating how optimistic he is for the company’s future He noted that, given the company’s investments so far, the company’s 2022 revenue projections now stand at between $90 million and $110 million On March…

Continue Reading

ThursdayMar 31, 2022 9:15 am

reBLOCKmiami to Showcase Top Trends and Where Real Estate, Crypto, and Blockchain Spaces Meet

On April 5, 2020, beginners, advocates (anyone interested in moving the real estate blockchain space forward), and professionals making a mark in the real estate sector – developers, brokers, traders, policymakers, financiers, startups, and agents – will congregate at the magnificent Hilton Miami Airport Blue Lagoon hotel for the reBLOCKmiami event, set to run from 8.30 am through 5.00 pm. The goal is to learn and network, focused on real estate blockchain, tokenization, non-fungible tokens (“NFTs”), and fintech startups, as well as Decentralized Finance (“DeFi”) real estate, regulatory updates, tradeable private real estate, and buying property in the metaverse. The…

Continue Reading

ThursdayMar 31, 2022 9:15 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Inks Retail Partnership with BESTIES Vegan Paradise to Strengthen its Retail Footprint and Product Offering

The partnership will see the rebranding of XMarket brick-and-mortar stores in Venice, and Hillcrest, California, under the BESTIES brand PlantX is confident that its partnership with BESTIES will accelerate the already significant growth for PlantX In the first month of the rebrand, PlantX posted a 30% growth in sales revenue Over the past year, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has embarked on an aggressive expansion campaign to strengthen its retail footprint and bring its products and services closer to consumers. This has seen the opening of various XMarket brick-and-mortar stores in strategic locations, the launch of shop-in-shops…

Continue Reading

ThursdayMar 31, 2022 9:15 am

Facebook’s Former Head of Advertising Joins NobleCon18 Lineup

Noble Capital Markets has announced that Rob Goldman will be a featured Metaverse panelist at NobleCon18, which feature presentations from 120 public companies on April 20 and 21 at The Guitar Hotel near Miami, FL. Joining Facebook (NASDAQ: FB) in 2012 reporting directly to CEO Mark Zuckerberg, Goldman was charged with growing and monetizing the burgeoning social media platforms (including subsidiaries such as Instagram). During his tenure at Facebook, revenues grew from $5 billion to over $70 billion in a span of seven years.  Goldman’s move to Facebook happened when his company, Threadsy, was acquired by the social media giant…

Continue Reading

ThursdayMar 31, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Reiterates Commitment to Operational Excellence, Advancing Berubicin Recognition

In a video message to shareholders, CEO John Climaco detailed the operational and clinical progress made by lead drug candidate Berubicin despite market volatility and share price fluctuations CNS is currently enrolling patients into a potentially pivotal global drug trial of Berubicin for recurrent glioblastoma multiforme Interim analysis of the trial is currently expected as early as the first quarter of 2023, once 30-50% of trial patients have been on the study for six months CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotech company specializing in developing novel treatments for primary and metastatic cancers of the brain and central nervous system,…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000